作者： sarah

TOKYO, Oct 18, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a part of Mitsubishi Heavy Industries (MHI) Group, has signed a new agreement with Emirates Central Cooling Systems Corporation PJSC (Empower), the world's largest district cooling services provider(Note1), to supply large-scale centrifugal chillers to Empower's District Cooling plants in Dubai, UAE.CEO H.E. Ahmad Bin Shafar and President Ito at the Signing CeremonyUnder the agreement, MHI Thermal Systems will supply 18 advanced chillers that will be ready for delivery from the beginning of 2025 for an aggregate cooling capacity of 56,250 refrigeration tons (RT) (Note2). They will be used in three District Cooling System (DCS) plants that Empower operates and will supply chilled water for cooling to residential, commercial, healthcare, educational, and multi-use projects. The agreement also includes a provision allowing Empower to increase the order up to 31 December 2024, potentially increasing the total capacity to 100,000 RT.MHI Thermal Systems has previously received an order for large-scale centrifugal chillers from Empower in 2021. The latest contract was received in recognition of the excellent chilling efficiency and environmental performance of MHI Thermal Systems chillers, as well as the operational performance and after-sales service from the previous order. Delivery is scheduled to begin sequentially from 2025, bringing the total number of chillers delivered to Empower to at least 46 units. The use of DCS is part of the Dubai government's long-term strategies, aiming to achieve savings of at least 30% by 2030 and 50% by 2050 in electricity, water and transport fuel consumption.MHI Thermal Systems and Empower held a contract signing ceremony in Dubai on October 8, attended by Empower CEO H.E. Ahmad Bin Shafar, and MHI Thermal Systems President Yoshihiro Ito.President Ito said: "We are proud that Empower has highly evaluated the performance and the quality of the after-sales service of the units previously delivered, and has once more chosen MHI Thermal Systems' chillers for these latest projects. We will continue improving energy efficiency while continuously enhancing operational and production effectiveness. We will continue implementing our advanced solutions to Empower's DCS plants so that our partnership will also contribute to the Dubai and the UAE's carbon emissions reduction strategy."Ahmad Bin Shafar emphasized that this deal offers both parties a significant opportunity to advance the district cooling sector and accelerate efforts toward a carbon-free future through energy-efficient solutions. He noted that these solutions reduce environmental impact and pave the way for a more sustainable tomorrow. Bin Shafar also highlighted that the agreement supports Empower's goal of upgrading its plants with innovative technologies that promote efficient, energy-saving production processes, aligning with the company's environmental and societal objectives and its commitment to safeguarding resources for future generations.Empower is responsible for more than 80% of Dubai's district cooling capacity, supplying chilled water for cooling from 87 district cooling plants, making it the world's largest district cooling services provider.MHI Thermal Systems, as a part of MHI Group, will continue to respond to customer needs and contribute to the realization of a carbon-neutral world through the supply of energy-efficient centrifugal chillers.(1) In terms of connected capacity(2) 1 refrigeration ton = approx. 3.516 kWAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Oct 18, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu and the Okinaga Research Institute at Teikyo University announced that, as of today, they will begin a full-scale joint research project for the development of a user experience (UX) platform. This platform will help to improve health consciousness and healthcare literacy by increasing patients’ understanding of their internal condition through the use of digital technology, such as extended reality (XR) and spatial computing (1).In this research project, Fujitsu and the Okinaga Research Institute will use XR and spatial computing to recreate a patient's internal anatomy in a virtual space, enhancing their understanding of the locations where health issues may arise. The two parties will examine how this visualization can foster health consciousness, behavioral change, and improved patient outcomes. The technology will be used in interviews with patients who have been advised to improve their lifestyle based on health check results. In addition, the two parties will also create an AI healthcare supporter avatar with generative AI technology to follow up with patients and will examine its effect on improving patient healthcare literacy.BackgroundIn recent years, lifestyle-related diseases have increased among both the elderly and younger populations. Preventing serious illness through lifestyle improvements is expected to reduce the national healthcare burden, improve corporate labor productivity, and enhance individual quality of life. Consequently, the Japanese Ministry of Health, Labour and Welfare requires health insurance societies to devise and implement data health plans. From this, effective improvements are being promoted through the plan-do-check-act (PDCA) cycle. In this cycle, data from the results of health checkups retained by health insurance societies and medical treatment bills are used to analyze the relationship between the data obtained from the medical examination and diseases to improve patient’s lifestyle.Improving lifestyles requires not only the support of healthcare providers but also a fundamental shift in individual mindset.In October 2022, Fujitsu and the Okinaga Research Institute started conducting research to eliminate the communication gap between doctors and patients by using XR, spatial computing, and generative AI in informed consent. This research led to the development such as virtual internal body models generated from patients’ biological data and technology for an AI medical supporter avatar. This research forms the basis of this latest project.Roles of Both Parties:1. Fujitsu- Conducting design research (2) with related parties and experts to identify hinderances to people’s awareness of true lifestyle improvement- Creating UX/UI scenarios for people to autonomously improve their lifestyles- Providing development support for an initial prototype, suggest improvements, and conduct a demonstration test with the prototype2. Okinaga Research Institute:- Providing medical expertise- Sharing visualization expertise in the area of medicine- Developing an initial prototype that uses organ dataFuture PlansBased on the results of this joint research project, Fujitsu and Teikyo University will contribute to improving people’s well-being and solving societal issues related to health by preventing lifestyle-related diseases through the societal implementation of health guidance that utilizes digital technology.(1) Spatial computing: A technology that seamlessly integrates physical and digital spaces, enabling people to interactively control information within that space.(2) Design research: Research with the aim of designing products and services from the user’s point of view. In this research, various information is collected and organized to identify potential customer needs and discover new issues and value.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press Contacts:Fujitsu LimitedPublic and Investor Relations DivisionInquiriesTeikyo UniversityHeadquarters Public Relations SectionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Oct 18, 2024 - (JCN Newswire via SeaPRwire.com) - TANAKA Holdings Co., Ltd. (Head office: Chuo-ku Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three finishers in the half marathon (elite athletes) and elite para-athletes (wheelchair and visual impairment) award categories at the Tokyo Legacy Half Marathon 2024. The Tokyo Legacy Half Marathon 2024 is organized by the Tokyo Marathon Foundation and will be held on October 20, 2024.*If the top three finishers above have a guide runner, a medal will also be provided to the guide runner.Medals Using Gently Expanding Curves to Represent the Event’s ConceptThe medals were designed based on the concept of the Tokyo Legacy Half Marathon: "We want to expand the opportunity for everyone to run, including those who have never run before, and create an event in which anyone can participate." The front of the medal features the event title, Tokyo Legacy Half Marathon 2024, written in English, and incorporates the event logo, which uses a motif of gently curved circles expanding outward. This logo represents the Earth’s continuous rotation, honoring the dedication of the runners who have trained tirelessly for 365 days leading up to the event. Additionally, the design of the Earth is reduced to about half the size of the medal to symbolize the half marathon.On the back of the medal, Tokyo Legacy Half 2024 is inscribed in braille, along with the TANAKA Precious Metals logo, and the word "FINISHER" and the event date. The ribbon is designed with the event logo, which resembles a tapestry of interwoven lines representing each runner, volunteer, and spectator.About the Tokyo Legacy Half Marathon 2024The Tokyo Legacy Half Marathon 2024 is a public participation half marathon (21.0975 km) that is half the distance of the Tokyo Marathon (42.195 km). It was born from the desire to create a half marathon that would give the extraordinary experience of running to everyone. This year, the event’s tagline is "If it’s a half marathon, I can barely make it, Maybe." aiming to offer a race where a wide variety of runners can enjoy the streets of Tokyo at their own pace.(Official website of the event: https://legacyhalf.tokyo/en/ )Since the inaugural event in 2022, TANAKA Precious Metals has been producing the medals awarded at the Tokyo Legacy Half Marathon, and this will be their third time providing them. In addition to the Tokyo Legacy Half Marathon, the company has also produced winner’s medals for the Tokyo Marathon, supported the promotion of para-sports as an official partner of the Japanese Para-Sports Association (JPSA), and manufactured and sold the official commemorative medals for the 1964 Tokyo Olympics. TANAKA Precious Metals will continue to produce medals made of precious metals and support the promotion of sports with the aim of contributing to the realization of a prosperous society.Overview of the Tokyo Legacy Half Marathon 2024 MedalsWeight, size and materialGold Medal: approx. 55g; approx. 55mm in diameter and approx. 2.3mm thick; pure silver with gold platingSilver Medal: approx. 55g; approx. 55mm in diameter and approx. 2.3mm thick; pure silverBronze Medal: approx. 45g; approx. 55mm in diameter and approx. 2.3mm thick; pure copper Race Information of the Tokyo Legacy Half Marathon 2024OrganizerTokyo Marathon FoundationCo-organizersTokyo Metropolitan Government; JAAF (Japan Association of Athletics Federations); Tokyo Sports Association for the DisabledManaging OrganizationTokyo Athletics AssociationOperation SupportJapan Para AthleticsSupporting OrganizationsJapan Industrial Track & Field AssociationOfficial PartnersSky Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; New Balance Japan, Inc.; Tokyo Tatemono Co., Ltd.; KINTETSU INTERNATIONAL; Hisamitsu Pharmaceutical Co.,Inc.; Tokyo Kiraboshi Financial Group, Inc.; TANAKA Holdings Co., Ltd.; Rokko Butter, Co., Ltd.; Photocreate Co.,Ltd.; SEIKO GROUP CORPORATIONOfficial SuppliersNIHON KOHDEN CORPORATION; Porsche Japan K.K.DateSunday, October 20, 2024 (rain or shine)Start/Finish AreaJapan National Stadium (Kasumigaoka-machi, Shinjuku, Tokyo) About TANAKA Precious MetalsSince its foundation in 1885, TANAKA Precious Metals has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,355 employees, the group’s consolidated net sales for the fiscal year ending December 2023, was 611.1 billion yen.TANAKA Holdings Websitehttps://www.tanaka.co.jp/english/Press inquiriesTANAKA Holdings Co., Ltd.https://tanaka-preciousmetals.com/en/inquiries-for-mediaPress Release: https://www.acnnewswire.com/docs/files/20241017.pdf  Copyright 2024 JCN Newswire via SeaPRwire.com.

Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ)(1) in the brain, a noted cause of Alzheimer’s disease(2), in a cohort study conducted in Usuki City, Oita from November 2022. A research paper reporting the details of this study was published on October 10, 2024, in the journal Alzheimer’s & Dementia: Translational Research & Clinical Interventions.This joint research attempts to develop Japan’s first diagnostic workflow for mild cognitive impairment (MCI) due to Alzheimer’s disease and mild dementia based on blood biomarkers. Comprising a phase 1 and phase 2 study, the phase 1 study uses frozen samples of blood plasma from a regional cohort collected by a prospective cohort study performed in Usuki City between 2015 and 2019 to evaluate the utility of blood biomarkers in predicting Aβ accumulation in the brain. The phase 2 study is a prospective study that uses blood plasma samples collected from 100 newly recruited subjects through diagnostic workflows adopted at all levels of health care, from primary care physicians to specialists certified by dementia-related societies, to evaluate the psychological impact on participants of different results and who discloses them.The research paper primarily compiles results from the phase 1 study. The ability of blood biomarkers to predict the results of amyloid PET scans(3) was evaluated in terms of an area under the curve (AUC) value. Blood biomarker measurements performed by Shimadzu resulted in an AUC value of 0.94 and identified PET-positive patients in the regional cohort with a high degree of accuracy. The joint research also revealed the possibility to predict the progression of clinical symptoms using baseline blood biomarker results, i.e., the progression from MCI due to Alzheimer's disease to Alzheimer's dementia from analysis of participant data over a seven-year observation period. Blood biomarker testing is less invasive than amyloid PET and cerebrospinal fluid testing(4), and could reduce patient stress and help predict the future onset of dementia if used as an alternative to these two diagnostic methods. The data collection stage of phase 2 is complete with plans in place to carry out data analysis and draft an overall report of the results of both phases of the joint research.The four parties involved in this joint research are committed to building an ecosystem that improves the early diagnosis of Alzheimer’s through diagnostic workflows adopted at all levels of health care from primary care physicians to specialists who are members of dementia-related societies, and through this research develop social infrastructure that ensures patients and their families live happy and fulfilling lives.Comment by Noriyuki Kimura, an Associate Professor at the Department of Neurology, Faculty of Medicine, Oita UniversityTreatment of Alzheimer’s disease is approaching a new turning point with the emergence of anti-amyloid beta antibodies that will require the diagnosis of Alzheimer’s disease at the MCI or early dementia stage. Biomarker-based tests to detect amyloid accumulation in the brain include amyloid PET scans and cerebrospinal fluid testing, but PET scans are expensive and cerebrospinal fluid testing is highly invasive. Blood biomarker testing is low-cost and less invasive, and its adoption promises to reduce the financial and physical burden on patients.(1) Amyloid beta is a protein believed to cause Alzheimer’s disease that accumulates in the brain to form senile plaques beginning around 20 years before the onset of Alzheimer’s disease.(2) Alzheimer’s disease is the most common cause of dementia and its key pathological hallmarks are senile plaques, neurofibrillary tangles, and neuronal cell death.(3) Amyloid PET is a brain imaging test that can visualize amyloid beta accumulation in the brain.(4) Cerebrospinal fluid testing collects cerebrospinal fluid and tests it for amyloid-β 42, amyloid-β 40, phosphorylated tau protein, and total tau protein, which are biomarkers of Alzheimer’s disease.Research Paper InformationJournal name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsTitle of paper: Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment.Authors: Takuya Ataka, Noriyuki Kimura, Naoki Kaneko, Teruaki Masuda, Yosuke Takeuchi, Kenichi Yabuuchi, Takeshi Mizukami, Tsukasa Takeuchi, Temmei Ito, Hideaki Tasai, Takehiko Miyagawa, Shunya Hanai, Shinichi Iwamoto, and Etsuro MatsubaraDOI: 10.1002/trc2.70008Related InformationNovember 22, 2022 Press releaseTo Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for DementiaShimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Researchwww.eisai.com/news/2022/news202280.html For Press and Media Inquiries, Please Contact:Shimadzu CorporationCorporate Communication Department Phone: +81-75-823-1110Eisai Co., Ltd.Public Relations Department Phone: +81-3-3817-5120Oita UniversityDepartment of Neurology, Faculty of Medicine Phone: +81-97-586-5814Usuki City Medical AssociationUsuki City Medical Association Office Phone: +81-972-63-0099 Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO and CAMBRIDGE, Mass., Oct 17, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the Therapeutic Goods Administration (TGA) of Australia issued a public statement about the initial decision not to register the humanized anti-solubleaggregated amyloid-beta (Aβ) monoclonal antibody lecanemab for the treatment of patients with mild cognitive impairment (MCI)due to Alzheimer’s disease (AD) and mild AD dementia.Eisai will request a reconsideration of this decision under Section 60* of the Therapeutic Goods Act within 90 days to make lecanemab available for eligible people living with early AD in Australia. Following Eisai’s request for review, the TGA will issue a final decision within 60 days of receiving Eisai’s request.Lecanemab is already approved in the United States, Japan, China, South Korea, Hong Kong, Israel UAE and Great Britain, and is being marketed in the U.S., Japan and China.Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision- making authority.*When we receive the outcome of the evaluation, Section 60 of the Australian legislation defines this as an “initial decision”. This is because the legislation states any decision considered an “initial decision” can be reviewed on request. This legislated process is referred to as a“request for a review of an initial decision” by the TGA. Note the specific part of the legislation that defines this is Section 60 of the Therapeutic Goods Act.About lecanemab (Leqembi®)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab is approved in the U.S., Japan, China, South Korea, Hong Kong, Israel, UAE and Great Britain for the treatment of MCI due to AD and mild AD dementia. Lecanemab’s approvals in these countries were primarily based on Phase 3 data from Eisai’s global Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statisticallysignificant results. The most common adverse events (>10%) in the lecanemab group were infusion reactions, ARIA-H (combined cerebral microhemorrhages, cerebral macrohemorrhages, and superficial siderosis), ARIA-E (edema/effusion), headache, and fall.Lecanemab is marketed in the U.S., Japan and China. Eisai has also submitted applications for approval of lecanemab in 10 countries and regions, including the European Union.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normaland have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti- amyloid therapy.About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisaiserves as the lead of lecanemab development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of AD treatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on theantibody back-up was signed in May 2015.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities,manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on X, LinkedIn and Facebook. The website and social media channels are intendedfor audiences outside of the UK and Europe. For audiences based in the UK and Europe, please visit www.eisai.eu and Eisai EMEA LinkedIn.About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.The company routinely posts information that may be important to investors on its website at www.biogen.com.Follow Biogen on social media – Facebook, LinkedIn, X, YouTube.ContactsMEDIA CONTACT:Eisai Co., Ltd.Public Relations Department+81-(0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 7974-879-419Emea-comms@eisai.netEisai Inc. (U.S.) Libby Holman+ 1-201-753-1945Libby_Holman@eisai.comMEDIA CONTACT:Biogen Inc. Jack Cox+ 1-781-464-3260public.affairs@biogen.comINVESTOR CONTACT:Biogen Inc. Stephen Amato+ 1-781-464-2442IR@biogen.comINVESTOR CONTACT:Eisai Co., Ltd.Investor Relations Department+81-(0)70-8688-9685Biogen Safe HarborThis news release contains forward-looking statements, about the potential clinical effects of lecanemab; the potential benefits, safety and efficacy of lecanemab; potential regulatory discussions, submissions and approvals and the timing thereof; thetreatment of Alzheimer's disease; the anticipated benefits and potential of Biogen's collaboration arrangements with Eisai; the potential of Biogen's commercial business and pipeline programs; including lecanemab; and risks and uncertainties associated with drug development and commercialization. These statements may be identified by words such as "aim," "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "may," "plan," "possible," "potential," "will," "would" and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small numberof research and development programs result in commercialization of a product. Results in early-stage clinical studies may notbe indicative of full results or results from later stage or larger scale clinical studies and do not ensure regulatory approval. You should not place undue reliance on these statements.These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including without limitation unexpected concerns that may arise from additional data, analysis or results obtained during clinical studies; the occurrence of adverse safety events; risks of unexpected costs or delays; the risk of other unexpected hurdles; regulatory submissions may take longer or be more difficult to complete than expected; regulatoryauthorities may require additional information or further studies, or may fail or refuse to approve or may delay approval of Biogen's drug candidates; including lecanemab; actual timing and content of submissions to and decisions made by the regulatory authorities regarding lecanemab; uncertainty of success in the development and potential commercialization of the medicine; failure to protect and enforce Biogen's data, intellectual property and other proprietary rights and uncertaintiesrelating to intellectual property claims and challenges; product liability claims; and third party collaboration risks, results ofoperations and financial condition. The foregoing sets forth many, but not all, of the factors that could cause actual results todiffer from Biogen's expectations in any forward-looking statement. Investors should consider this cautionary statement as wellas the risk factors identified in Biogen's most recent annual or quarterly report and in other reports Biogen has filed with the U.S.Securities and Exchange Commission. These statements speak only as of the date of this news release. Biogen does notundertake any obligation to publicly update any forward-looking statements. Copyright 2024 JCN Newswire via SeaPRwire.com.

NEC Corporation (NEC; TSE: 6701) and NEC Personal Computers, Ltd. (NECPC) today announced an agreement to transfer the sales functions related to NEC-brand PCs for commercial customers from NEC to NECPC. The transfer is scheduled to be completed by the end of March 2025. Once the transfer is complete, NECPC will be responsible for the development, design, manufacturing, marketing and sales of both NEC-brand PCs for consumer and commercial customers.NEC brand PCs for commercial customers are provided to enterprises, organizations and educational institutions under product names such as "VersaPro" and “Mate", and have a reputation as reliable products that support businesses and society. By integrating the management resources of NEC and NECPC, NECPC will develop more competitive products that meet the needs of its customers. In addition, NECPC will enhance the total value of its products by enabling its dedicated PC sales team to work with sales partners to provide faster customer care. Furthermore, NECPC will support the success of its customers by prioritizing the resolution of their challenges and through continuous innovation.“I am confident that this transfer of functions will strengthen the competitiveness and product appeal of NEC-brand PCs for corporate customers. We will also support our customers' workstyle transformation and DX promotion by combining NEC's value creation model, NEC BluStellar, with PCs," said Tetsuhiko Kimura, Corporate Executive Vice President, NEC Corporation.“Since being launched as a joint venture between NEC and Lenovo in 2011, NECPC has always focused on solving the challenges of our customers and society, and has worked on product innovation. By building a system that covers everything from development to sales, I am confident that NECPC will be able to contribute to the success of our customers even more," said Taro Hiyama, President, NEC Personal Computers.About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.  Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Oct 17, 2024 - (JCN Newswire via SeaPRwire.com) - TANAKA Kikinzoku Kogyo K.K. (Head office: Chuo-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which develops industrial precious metal products as one of the core companies of TANAKA Precious Metals, has announced the development of TK-SK, a palladium alloy designed for probe pins used in the final testing stage (post-processing) of semiconductor packages. This new product will be showcased via a panel display at SWTest Asia 2024, an exhibition scheduled for October 24–25, 2024, in Fukuoka Prefecture, Japan, with samples available for shipping before the end of the year.Key Features of “TK-SK”:640HV Hardness: This palladium alloy offers maximum hardness of 640HV, making it ideal for use in test socket applications, particularly in the final continuity testing stage (back-end process).TANAKA Kikinzoku Kogyo has manufactured and supplied a range of precious metals for probe pins used in testing equipment in the front-end and back-end processes of semiconductor manufacturing.As a palladium alloy for probe pins, TK-SK exhibits maximum hardness of 640HV that makes it suitable for use in test socket applications mainly in the final continuity testing stage (back-end process).Demand for high-hardness probe pins has increased in recent years. However, one common challenge with harder materials is that they can be more difficult to process and are prone to breaking during machining. Additionally, palladium alloys on the market previously had a maximum hardness of around 560HV. Through its unique processing technology, TANAKA Kikinzoku Kogyo has successfully developed TK-SK with a hardness of 640HV. By 2028, the company aims to ship 1.5 times the volume of its existing products.Pogo pin-type probe pins are typically used in test sockets. During testing, the tip or plunger of the probe pin can become deformed due to friction from contact with substrates. Solder may also adhere to the plungers, needing regular cleaning, which further increases the risk of deformation due to friction. High-hardness probe pins, like TK-SK, reduce wear-related deformation, leading to longer service life and lower maintenance costs for semiconductor test equipment.Looking ahead, TANAKA Kikinzoku Kogyo plans to continue contributing to the development of the semiconductor market, which is expected to experience significant growth in the coming years.TK-SK Properties (Reference Values)Exhibition detailsExhibition name: SWTest Asia 2024Dates: October 24 (10:00–15:30) and October 25 (10:00–16:00), 2024Venue: Hilton Fukuoka Sea Hawk, JapanOfficial website: https://www.swtestasia.org/Exhibitor: TANAKA Kikinzoku Kogyo K.K.Booth No.: 210Panel display: Palladium alloy for probe pins (TK-SK wire, TK-FS wire and sheet), copper-silver alloy for probe pins (TK-101 sheet), and precious metal plating solution for probe cardsAbout TANAKA Precious MetalsSince its foundation in 1885, TANAKA Precious Metals has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,355 employees, the group’s consolidated net sales for the fiscal year ending December 2023, was 611.1 billion yen.Global industrial business websitehttps://tanaka-preciousmetals.com/en/Product inquiriesTANAKA Kikinzoku Kogyo K.K.https://tanaka-preciousmetals.com/en/inquiries-on-industrial-products/Press inquiriesTANAKA Holdings Co., Ltd.https://tanaka-preciousmetals.com/en/inquiries-for-media/Press Release: https://www.acnnewswire.com/docs/files/20241017_EN.pdf  Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Oct 16, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has completed the construction of a 50-megawatt (MW) class woody biomass-fired power plant in the city of Hyuga, in Miyazaki Prefecture, successfully handing over of the facility within the contract period. The Hyuga Biomass Power Plant, developed by a consortium led by MHI as part of a full turnkey solution for engineering, procurement, and construction (EPC), will be operated by Hyuga Biomass Power Co., Ltd., a special purpose company (SPC).Hyuga Biomass Power PlantThe power plant facility comprises a steam turbine, circulating fluidized bed (CFB) boiler, generator, and other equipment that deliver high combustion efficiency for biomass power generation. Improving power generation and fuel efficiency will lead to further reductions in the plant's environmental impact. The SPC that will operate the plant is jointly owned by Osaka Gas Co., Ltd., ITOCHU Corporation, Tokyo Century Corporation, and Tokyo Energy & Systems Inc. Based on the EPC contract, MHI leveraged its experience with numerous power systems to build and supply the main power generating equipment, including the steam turbines, CFB boiler, and other large auxiliary machinery. MHI Group company Mitsubishi Heavy Industries Power Environmental Solutions, Ltd. provided the air quality control systems (AQCS), while Mitsubishi Electric Corporation supplied the generator and electrical components,* and Fujita Corporation handled the civil engineering and construction.Going forward, MHI Group will continue to focus efforts on the further spread of renewable energy power generation systems such as biomass fuel, which makes effective use of resources and is beneficial in reducing environmental loads, contributing to the stable supply of energy and the conservation of the global environment.*The generator and related electrical components were supplied by Mitsubishi Generator Co., Ltd., which was formed on April 1, 2024, through the integration of MHI and Mitsubishi Electric Corporation's power-generator systems businesses. Mitsubishi Electric handled the power receiving and transforming equipment.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Oct 16, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) held a commemorative ceremony on October 15 to celebrate reaching cumulative orders for 150 gas turbines units through Dongfang Turbine Co., Ltd. (Deyang, Sichuan Province), a subsidiary of Dongfang Electric Corporation, MHI's partner for the gas turbine business in China.Commemorative CeremonyThe ceremony for the 150-unit milestone was attended by Zhang Yanjun, President of Dongfang Electric, with Liu Hui, Chairman of Dongfang Turbine. MHI was represented by Toshiyuki Hashi, Executive Vice President/President and CEO, Energy Systems, Takashi Tozawa, Senior Vice President/Vice President, Energy Systems, and Takashi Kubo, Senior Vice President/Chief Regional Officer, China. Also attending as a special guest was Qin Zhaohui, President of China Huaneng Group Co.,Ltd., Jiangsu Branch, the customer for the 150th unit.Dongfang Turbine is one of three major manufacturers of heavy electrical equipment in China, handling manufacturing and repair services for steam turbines, gas turbines, and auxiliary plant equipment used for power generation. Since 2003, MHI has gradually expanded its licensing of large-scale gas turbines to the company. In 2015, Mitsubishi Power (China) Co., Ltd., the headquarters for MHI's thermal power systems operations in China, opened the Chengdu Branch in Chengdu, Sichuan Province, with the aim of strengthening the collaboration. In addition, MHI and Dongfang Turbine provide localized after-sale services through Mitsubishi Heavy Industries Dongfang Gas Turbine (Guangzhou) Co., Ltd., a joint venture established in 2004 to enable a swift response to local customer needs.Electricity demand continues to rise in China, and the gas turbine market remains robust against the backdrop of increasing demand for replacing aging coal-fired power generation facilities, as well as demand for load-following power sources in line with the expansion of renewable energy. Amid the rising demand in China for high-efficiency gas turbine combined cycle (GTCC) power generation equipment as a means of reducing environmental loads, MHI has steadily accumulated orders for its highly competitive gas turbines, owing to its state-of-the-art and high-efficiency models, and hydrogen co-firing technology. Shipments of gas turbines made in collaboration with Dongfang Turbine reached 100 units in March 2024, and the number of cumulative orders for gas turbines has now reached the 150 unit mark.Going forward, MHI, along with its power solutions brand, Mitsubishi Power, will continue to work in cooperation with Dongfang Electric and Dongfang Turbine for the development of electric power in China, and contribute to the improvement of energy efficiency and the reduction of environmental impacts.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Oct 16, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” (mecobalamin) has received the Good Design Award 2024 (by the Japan Institute of Design Promotion) for its light-proof vial packaging.“Rozebalamin for Injection” was approved in Japan on September 24, 2024 as a treatment for amyotrophic lateral sclerosis. Its active ingredient is mecobalamin, which was developed as a freeze-dried formulation which is dissolved into a solvent at the time of administration. Mecobalamin is chemically unstable when exposed to light, therefore requiring a higher level of light-protection than that of the commonly used light- blocking film made by depositing aluminum onto a PET film (aluminium-deposited PET), from the time of distribution/storage until immediately before administration. However, there is also some necessity for visibility, such as the ability to visually confirm the medication inside the vial at the time of use and see the needle tip when extracting the medication with a syringe.For Rozebalamin, packaging was created with a high level of light-protection by applying a black print to aluminium-deposited PET. While the entire vial is covered by the light-blocking packaging, a resealable window to visibility to inspect the solution inside, and the neck of the vial allows that can be peeled back. In addition, perforations were not added to the film with the aim of maintaining the high capacity for light- protection. In doing so, the conflicting issues of increasing light-protection while maintaining visibility were solved, which was also highly evaluated in this selection. This packaging was co-developed with IL Pharma Packaging Co., Ltd. (Headquarters: Aichi), and the award was also presented to both companies.Eisai considers neurology a therapeutic area of focus. As a human healthcare company, Eisai is committed to further addressing the diverse needs of, and increasing the benefits of, patients, their families, and healthcare professionals, by providing high-quality and easy-to-use Rozebalamin as a new treatment option for ALS patients.About Good Design AwardA Japanese design evaluation and promotion mechanism that was first established in 1957 as the Good Design Product Selection System. As a global design award with participation from numerous domestic and international companies and organizations, it is held annually with the aim of improving the quality of life and utilizing design to solve social issues and themes. The "G Mark," which symbolizes the award, is widely recognized as an emblem of excellent design. www.g-mark.org/en.Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Oct 16, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has begun a project to develop a disinformation countermeasure platform alongside a consortium of leading academic and private sector organizations. Fujitsu was selected as a primary operator for this initiative in July 2024 through a public call for proposals by Japan’s New Energy and Industrial Technology Development Organization (“NEDO”) (1). The effort is part of the Key and Advanced Technology R&D through Cross Community Collaboration Program (“K Program”) (2), which was established with the collabor"ation of Japan’s Cabinet Office, the Japanese Ministry of Economy, Trade and Industry (METI), and other related Japanese ministries, to strengthen and drive Japan’s economic security. The consortium, assembled by Fujitsu, includes the National Institute of Informatics (NII), NEC Corporation, Keio Research Institute at SFC, Institute of Science Tokyo (formerly Tokyo Tech), The University of Tokyo, University of Aizu, Nagoya Institute of Technology, and Osaka University.The project aims to develop the world’s first comprehensive disinformation countermeasure platform that can process false information from initial detection to evidence gathering, analysis, and evaluation, with development slated for completion by the end of fiscal year 2025.Vivek Mahajan, Corporate Vice President, CTO, CPO, Fujitsu Limited, comments: “We are excited to be working on this initiative with a top-tier consortium of Japanese academic and private sector organizations that have a proven track record of combating disinformation. In addition to our consortium partners, Fujitsu will collaborate with relevant government agencies and other organizations to develop a robust countermeasure solution and contribute to solving this serious societal challenge.”Figure 1. Consortium member organizationsAs prime operator of this project, Fujitsu will lead the R&D efforts, technology integration, and construction of the overall platform. Leveraging the latest trends in disinformation tactics and technologies, Fujitsu will also create use cases for public and private sector organizations, facilitating the practical application of the research findings.Technology to be developed and consortium roles1. Information analysis by media type and disinformation detection (Responsible parties: NII, NEC)NIILeveraging its track record in the field of fake media detection, NII will develop a technology to detect deepfakes of images, video and audio from social media posts and other content. The technology will identify how the media content has been created and any areas that have been manipulated and assign a confidence score which will be provided as supporting evidence.NECNEC will develop media understanding technology that extracts content including images, video and audio as text and uses it to analyze matches with social media posts and to collect supporting information.2. Evidence/endorsement management (Responsible parties: Keio Research Institute at SFC, Fujitsu, Osaka University)Keio Research Institute at SFC and FujitsuKeio Research Institute at SFC which has a track record in the field of trusted internet architecture and Fujitsu develop technology to integrate evidence collected from the internet, including the analysis results from technology 1 above. This evidence will be structured and stored as an evidence/endorsement graph (3) to verify authenticity and assess impact.Osaka UniversityOsaka University will leverage its expertise in IoT data analysis to develop technology to collect sensor data as a source of evidence. In cases where information for the target area is incomplete, the system will infer evidence based on available data from neighboring areas. This proactive, AI-driven evidence gathering, mimicking human information collection and inference, is a highly advanced initiative.3. Comprehensive authenticity determination (Responsible parties: Fujitsu, Nagoya Institute of Technology)Fujitsu- Fujitsu will develop technology to analyze the consistency of evidence linked to target information using evidence/endorsement graphs from technology 2. This technology enables comprehensive information authenticity analysis, presenting the results and supporting evidence in a user-friendly manner.- Fujitsu will also develop a specialized Japanese LLM for disinformation countermeasures, utilizing its supercomputer (Fugaku) and LLM (Takane) expertise. This specialized LLM will enhance comprehension of news and social media data, improve logical reasoning capabilities, and enable high-speed, high-accuracy inference for authenticity verification while mitigating hallucinations.Nagoya Institute of TechnologyFujitsu will collaborate with Nagoya Institute of Technology to develop a user interface and information provision technology based on cognitive science, considering factors related to human psychology (e.g., continued influence effect). This will help users to accurately judge the truthfulness of information and encourage appropriate actions, including making efforts to avoid the unintentional spread of false information.4. Evaluation of disinformation impact (Responsible parties: Institute of Science Tokyo, The University of Tokyo, Aizu University)Institute of Science Tokyo, The University of Tokyo, and University of Aizu, with their expertise in computational social science related to social media, will develop technology to assess the impact of disinformation. By extending LLMs to build an AI model for disinformation assessment, the three parties will analyze characteristics of disinformation, such as similarity to past disinformation and proliferation speed, focusing on the source, content, and social context of messages from social media data. This will allow for the evaluation of metrics such as proliferation scale and social impact. This development of technology to visualize and quantitatively assess the social impact of disinformation represents a highly advanced endeavor.Figure 2. Diagram of the disinformation countermeasure platformFuture PlansIn fiscal year 2024, the project will focus on analyzing use cases for private companies and public institutions, defining functional requirements, and initiating R&D of individual technologies, with the final system scheduled for development by the end of fiscal year 2025.By developing this platform, Fujitsu and its consortium partners aim to contribute to economic stability in the face of increasing disinformation risk and with NEDO’s support aid in increasing new industry development, international competitiveness, and strengthening Japan’s global position.Comments from partner academic-industrial organizationsProf. Junichi Yamagishi, National Institute of Informatics, comments:“Combating disinformation demands a sophisticated, integrated arsenal of technologies. Leveraging years of cutting-edge research in technology for detecting fake media, we are going to create a robust foundation for a powerful disinformation defense system.”Motoo Nishihara, Corporate Executive Vice President and CTO, NEC Corporation, comments:"We are excited to join this important initiative. As AI is linked to the production of increasingly sophisticated disinformation, AI-powered countermeasures are paramount. Leveraging NEC's cutting-edge AI technologies, we aim to contribute to the development of truly effective solutions."Prof. Hiroyuki Kusumoto, Faculty of Environment and Information Studies, Keio University, and Project Professor Shigeya Suzuki, Graduate School of Media and Governance, Keio University, comment:“Information on the internet nowadays is not only transmitted by individuals, but also by information systems utilizing LLMs. Leveraging cutting-edge digital identity technology, we will create a platform that meticulously tracks sender identity and information relationships, enabling multifaceted analysis for more informed and accurate end-user decision-making.”Prof. Kazutoshi Sasahara, Institute of Science Tokyo, comments:“The increasing scale and sophistication of disinformation pose a grave threat to our daily lives and democracy. With AI making truth increasingly indistinguishable from falsehood, developing technologies to assess the influence of disinformation is a critical, urgent task. We aim to spearhead the development of widely accessible tools to combat this escalating challenge.”Prof. Masashi Toyoda, The University of Tokyo, comments:"We are excited to have the opportunity to collaborate with experts from diverse fields in tackling the challenge of misinformation. We will leverage a wide range of expertise and technologies to build a foundational infrastructure for assessing the impact of disinformation."Yasuhiro Hashimoto, Senior Associate Professor, Aizu University, comments:“The generation and spread of disinformation pose a grave threat to societal stability and national security, demanding a multidisciplinary approach drawing on informatics, engineering, social sciences, and more. We will develop technologies to visualize the large-scale structures and complex relationships in which disinformation circulates, and build an environment where the dynamics of disinformation can be quickly viewed and analyzed.”Prof. Yuko Tanaka, Nagoya Institute of Technology, comments:"I am pleased to participate in this project that integrates cutting-edge technologies to address the increasingly sophisticated and serious circulation of disinformation. I am contributing to the development of interface design that effectively communicates the results—from disinformation detection to evaluation—by considering human cognitive characteristics."Shin’ichi Arakawa, Associate Professor, Osaka University, comments:"We are excited to be involved in R&D that addresses the growing problem of disinformation. Within the project, we will focus on practical research and development, and on delivering real-world impact, going beyond theoretical evaluation."(1) Key and Advanced Technology R&D through Cross Community Collaboration Program Press Release regarding the Key and Advanced Technology R&D through Cross Community Collaboration/Development of Disinformation Analysis Technology (K Program) :www.nedo.go.jp/koubo/CD2_100359.html (in Japanese)[2] Key and Advanced Technology R&D through Cross Community (“K Program”) :www8.cao.go.jp/cstp/anzen_anshin/kprogram.html (in Japanese)[3]Evidence/Endorsement Graph :Information added to the target information that serves as the basis for authenticity judgment, such as the sender (person or organization and its attributes), location, and date.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.About National Institute of InformaticsNII is Japan's only academic research institute dedicated to the new discipline of informatics. Its mission is to "create future value" in informatics. NII conducts both long-term basic research and practical research aimed at solving social problems in a wide range of informatics research fields, from fundamental theories to the latest topics, such as artificial intelligence, big data, the Internet of Things, and information security.As an inter-university research institute, NII builds and operates academic information infrastructure essential for the research and educational activities of the entire academic community (including the Science Information Network) as well as developing services such as those that enable the provision of academic content and service platforms.https://www.nii.ac.jp/en/.About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at http://www.nec.com.About Keio Research Institute at SFCThe Keio Research Institute at SFC was established in 1996. In its capacity as an academic entity and research institute affiliated with the Graduate School of Media and Governance, Graduate School of Health Management, Faculty of Policy Management, Faculty of Environment and Information Studies, and Faculty of Nursing and Medical Care, the institute serves as a platform for promoting advanced research activities and collaborative initiatives involving the community and local regions. By 2021, the institute had more than 40 laboratories (transdisciplinary research groups with advanced research missions) and more than 30 SFC research consortiums (joint research deployed by the Keio Research Institute at SFC in conjunction with a number of external organizations), and together with approximately 500 senior and guest researchers from various industries, government, and academia, aims to develop unique research to create a vital society. In this manner, the Keio Research Institute at SFC has an impressive wealth of experience and track record in the creation of pioneering knowledge through collaborations among industry, government, and academia.About Institute of Industrial Science, The University of TokyoThe Institute of Industrial Science, The University of Tokyo (UTokyo-IIS) is one of the largest university-attached research institutes in Japan. UTokyo-IIS is comprised of over 120 research laboratories—each headed by a faculty member—and has over 1,200 members (approximately 400 staff and 800 students) actively engaged in education and research. Its activities cover almost all areas of engineering. Since its foundation in 1949, UTokyo-IIS has worked to bridge the huge gaps that exist between academic disciplines and real-world applications.About University of AizuNurtures talent who will exercise leadership in the knowledge-based society.Nurtures computer scientists and highly-skilled computer engineers who will create and exploit "knowledge" for the new era.Has first-class faculty members from almost twenty countries around the world.Provides an outstanding computer environment unparalleled by other universities.Established the graduate school open to the world, where English is used as the common language.Fosters students' latent limitless creativity by training critical thinking and appreciating their curiosity, free from preconceived ideas.About Nagoya Institute of TechnologyNagoya Institute of Technology (NITech) was founded as the first national institution of higher education in central Japan in order to develop the region as Japan’s center of industry. Maintaining a respect for this historic mission and acting as one of the leading engineering institutes in Japan, NITech shall therefore make its fundamental mission as follows: developing revolutionary science and technologies, fostering rich human resources, and contributing to peace and social welfare of the future by acting as a source to consistently produce and develop new industries and culture.About Osaka UniversityOsaka University was founded in 1931 as one of Japan’s imperial universities through strong demand from political and business circles in Osaka, as well as the people of Osaka City and Prefecture. The spiritual roots of Osaka University can be found in Kaitokudo and Tekijuku, educational institutions of the Edo period. After its merger with Osaka University of Foreign Studies in 2007, Osaka University became a comprehensive university with its own School of Foreign Studies. Boasting 11 undergraduate schools, 15 graduate schools, and 6 affiliated research institutes excelling in the fields of the humanities and social sciences, medicine, dentistry, pharmacy, science, and engineering, Osaka University is one of Japan’s premier comprehensive research universities.Osaka University will celebrate the 100th anniversary of its founding in 2031. We will contribute to the creation of a society where each member feels worth living through co-creation with diverse stakeholders to solve local and global challenges in accordance with the university's motto of “Live Locally, Grow Globally.”Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiriesNational Institute for Informatics Research Organization of Information and SystemsPublicity Team, Planning Division, General Affairs DepartmentTEL: +81-3-4212-2164E-mail: media@nii.ac.jpNEC Corporate CommunicationsE-mail: press@news.jp.nec.comKeio Research Institute at SFCOffice of Research Development and Sponsored Projects Shonan Fujisawa CampusE-mail: kri-pr@sfc.keio.co.jpThe Institute of Industrial Science, The University of TokyoPublic Relation OfficeE-mail: pro@iis.u-tokyo.ac.jpUniversity of AizuPlanning and Collaboration DivisionPlanning and Public Relations SectionTEL: +81-242-37-2510E-mail: cl-planpr@u-aizu.ac.jpNagoya Institute of TechnologyFoundations GroupProfessor TANAKA YukoE-mail: tanaka.yuko@nitech.ac.jpOsaka UniversityGraduate School of Information Science and TechnologyAssociate Professor Shin’ichi ArakawaE-mail: arakawa@ist.osaka-u.ac.jp Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Oct 16, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) announced that it has invested in Koloma, a startup company headquartered in Denver, Colorado. The investment has been executed through Mitsubishi Heavy Industries America, Inc. (MHIA), which joins a syndicate of investors, including Breakthrough Energy Ventures, Amazon's Climate Pledge Fund, United Airline's Sustainable Flight Fund and Energy Impact Partners.Koloma Natural Hydrogen Exploration SiteKoloma is a geologic hydrogen company that leverages its technology, proprietary data, and human capital advantages to identify and commercialize geologic hydrogen on a global scale. Koloma is actively engaged in exploration and appraisal of assets that will play a significant role in global decarbonization efforts. As the rapidly emerging geologic hydrogen industry takes shape, Koloma's data-driven approach helps power the discovery of geologic hydrogen resources around the world."Building a hydrogen solution ecosystem is one of the core strategies in the energy transition business for MHI," said Takajiro Ishikawa, President and CEO of MHIA. "In MHI's role as a value chain solutions provider, we are aiming to accelerate the hydrogen economy by both offering cutting-edge technologies and enabling breakthrough innovations in the hydrogen space through investments into startups.""We are excited to welcome Mitsubishi Heavy Industries to the Koloma family," said Pete Johnson, CEO of Koloma. "Partnerships with industrial leaders like MHI will maximize the positive impact geologic hydrogen can have as a new clean primary energy source. We look forward to collaborating and innovating together to drive progress in this field and in the broader energy transition."MHI Group is collaborating with and investing in partners to develop innovative technologies that will help to decarbonize existing infrastructures and help build a hydrogen ecosystem to contribute towards achieving a decarbonized society. The Company will continue to enhance and diversify its solutions portfolio to provide customers with alternative decarbonization technologies to achieve their net zero goals.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

KAWASAKI, Japan, Oct 15, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the development of an application that leverages AI technology to enhance mobile network communication quality, while achieving energy savings and optimizing network operations. This development is part of the Research and Development Project of the Enhanced Infrastructures for Post-5G Information and Communication Systems (hereafter NEDO-led project) (1) conducted by the New Energy and Industrial Technology Development Organization (NEDO). Fujitsu, which has a successful track record of introducing radio unit (RU) products to the global market, will incorporate this technology into its O-RAN (2) compliant Service Management and Orchestration (SMO) (3) system, FUJITSU Network Virtuora Service Management and Orchestration. Fujitsu will implement a gradual global rollout of the technology to mobile network operators starting in November 2024 by leveraging the footprint it has already cultivated in RU.This application comprises three key technologies:An AI-powered technology that can estimate smartphone users’ quality of experience (QoE) on their networks in real time.A technology that detects early signs of increased communication traffic and proactively prevents network quality degradation.A technology that detects network quality degradation and redefines the area covered by peripheral base stations to maintain optimal quality.Fujitsu verified the effectiveness of these technologies in August 2024 using real commercial data from mobile network operators (4) under conditions closely resembling actual operating environments.This application will ensure a seamless and reliable connection for mobile network users, not only during normal operations but also during emergencies and periods of increased network traffic, ultimately enhancing user convenience, satisfaction, and safety in critical situations. For mobile network operators, the application will reduce operational costs and save power through optimized operations.BackgroundAs digital transformation (DX) accelerates globally, the adoption of 5G mobile networks is rapidly expanding as a key infrastructure component. Mobile network operators are expected to further enhance their capabilities, including ultra-low latency and simultaneous connectivity, while ensuring network quality at user and application levels. Furthermore, the RAN (Radio Access Network) domain is undergoing open and virtualized transformation based on the O-RAN concept, leading to anticipated reductions in total cost of ownership (TCO).The three technologies in this application operate on the RIC (5) deployed within the O-RAN compliant SMO, contributing to the intelligent automation and self-sufficiency of RAN.Development achievements1. Real-time QoE estimation and quality assurance using AIThis technology estimates QoE in real-time and automatically switches users to other base station network areas when QoE degradation is detected. It is a world-first, enabling the creation of AI models that can easily estimate QoE for individual applications by selecting feature values from statistical data (KPIs) calculated from high-speed packet analysis for 100 Gbps RAN traffic. This approach allows for flexible adaptation to various applications.By accurately understanding the QoE of each user and assigning the necessary resources, this technology ensures user convenience and satisfaction while simultaneously suppressing excessive resource allocation. This results in a 19% increase in the number of users that can be accommodated per base station (6).Figure 1: QoE estimation based on packet analysis2. Proactive base station activation/deactivation for quality maintenance and energy savingsFujitsu has developed a technology that utilizes AI to anticipate increased communication traffic and proactively activate previously dormant base stations to prevent degradation in user communication quality.Previously, energy savings were achieved by monitoring traffic in each area in real-time and putting unnecessary base stations into sleep mode. This world first technology goes a step further by detecting unusual increases in pedestrian traffic, such as those associated with local events, and predicting subsequent traffic increases at the grid level (7). This predictive technology has been proven to successfully activate base stations in advance without impacting user quality 99.8% of the time during the verification period.This enables pinpoint activation and deactivation of base stations based on traffic conditions, achieving a balance between maintaining QoE and saving energy when combined with the energy-saving application announced by Fujitsu in December 2023 (8).3. Detection of service quality degradation and area redesign for service quality maintenanceTraditional anomaly detection technologies for single cells (9) struggled to differentiate between simple load reductions and actual anomalies. Fujitsu's new technology addresses this by comparing traffic trends across surrounding cells using AI, achieving a fault detection accuracy rate of over 92%. This technology supports both supervised learning with limited fault data as well as unsupervised learning. By understanding the service impact including cell overlap, it is possible to make a judgement on which areas should be recovered first.When this anomaly detection technology identifies areas undergoing significant service impact, it utilizes a radio propagation prediction model that considers path loss (10) in the real field, in addition to the direction and load conditions of surrounding cells, to calculate the optimal tilt angle for surrounding cells. This minimizes the impact on service quality caused by faulty cells. As a result, recovery time from anomalies such as equipment failure, which previously took 24 hours, has been reduced to less than one hour, minimizing the impact on users.Figure 2: Service quality degradation detection and recoveryFuture PlansFujitsu will continue to contribute to the realization of a safer, more secure, and sustainable society by providing O-RAN products using AI-centric technologies for networks that support applications and services across industries.[1] NEDO-led project :Project name: Research and Development Project of the Enhanced Infrastructures for Post-5G Information and Communication Systems (JPNP20017) (Commissioned)Period: FY2021 - 2024Overview: Research and Development Project of the Enhanced Infrastructures for Post-5G Information and Communication Systems[2] O-RAN :O-RAN refers to a Radio Access Network (RAN) built based on open interface specifications developed by the O-RAN ALLIANCE.[3] Service Management and Orchestration (SMO) :In the O-RAN architecture, Service Management and Orchestration (SMO) defines a system that manages the operation, maintenance, and optimization of RAN, as well as its lifecycle.[4] Commercial data from mobile network operators :This refers to data collected by mobile network operators during their actual operations. This data is used in AI development for this research and development project.[5] RIC :Abbreviation for RAN Intelligent Controller, a controller that autonomously executes and controls RAN parameter settings and operational optimization.[6] A 19% increase in the number of users that can be accommodated per base station :This figure was calculated based on a comparison of cell-based performance measurements and QoE-based performance measurements in Fujitsu's lab environment.[7] Grid :A grid refers to a section on a map based on latitude and longitude.[8] The energy-saving application announced by Fujitsu in December 2023 :This refers to an energy-saving application that applies Fujitsu's AI technology to estimate communication traffic based on the distribution of user location information in the mobile network.Press Release: “Fujitsu leverages AI technology to realize energy saving in network operations”[9] Cell :A cell is the smallest unit of a communication area formed by the radio waves of a base station.[10] Path loss :Path loss refers to the attenuation of radio waves as they pass through the air or are blocked by obstacles.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.